Argent BioPharma Limited

LSE:RGT Stock Report

Market Cap: UK£4.0m

Argent BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:RGT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
15 Oct 24BuyUK£840,668Roby ZomerIndividual4,000,000UK£0.21
10 Sep 24BuyUK£256,428Roby ZomerIndividual1,258,500UK£0.20

Insider Trading Volume

Insider Buying: RGT insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RGT?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,170,4392.16%
Public Companies3,913,8127.21%
Private Companies10,254,21818.9%
Individual Insiders12,935,14023.8%
General Public25,998,66047.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 48.7%.

Top Shareholders

Top 11 shareholders own 52.1% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.1%
Roby Zomer
9,292,320UK£693.1k619%no data
15.4%
Oak Capital Partners Llc
8,370,718UK£624.4k0%no data
7.21%
CoinShares International Limited
3,913,812UK£291.9k0%no data
3.56%
Shachar Shimony
1,933,000UK£144.2k2,680%no data
2.32%
Bioheka Limited
1,258,500UK£93.9k1,080%no data
2.06%
Yifat Steuer
1,117,194UK£83.3k-93.9%no data
1.83%
Spreadex.com Limited, Asset Management Arm
993,953UK£74.1k0%0.34%
1.15%
A1 Invest Llc
625,000UK£46.6k0%no data
1.09%
Amir Polak
592,626UK£44.2k0%no data
0.32%
Premier Fund Managers Ltd.
176,203UK£13.1k0%no data
0.00052%
Barclays PLC Private Banking & Investment Banking Investment
283UK£21.10%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 01:41
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Argent BioPharma Limited is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Salvatore Gaetano VerdolivaCanaccord Genuity
Robin DavisonCapital Network by Proactive Investors
Maxim JacobsEdison Investment Research